Research indicated an increase in ABL2 levels in renal cell carcinoma (RCC) samples, with higher ABL2 expression correlating with poorer RCC overall survival in the TCGA database for patients with RCC 9. The gene discussed is ABL2; the disease is hereditary clear cell renal cell carcinoma.